Who to call at Marker Therapeutics, Inc., and when
Fundz watches for the moments Marker Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Marker Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Marker Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Marker Therapeutics, Inc.. With Fundz connected, it knows.
Marker Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
tapimmune.comAI Executive Summary
AI-powered analysis of 8-K filing content
Marker Therapeutics appointed Kathryn Penkus Corzo, a pharmaceutical industry executive, to its Board of Directors effective November 1, 2025, and disclosed the appointment in a November 5, 2025 press release. The filing describes stock option grants to Ms. Corzo and a 250,000-option award to CEO Juan Vera, a governance change with limited direct financial impact.
Key Takeaways
Kathryn Penkus Corzo joined the Board effective November 1, 2025, after appointment on October 31, 2025, adding pharmaceutical industry experience including her former role as President and COO of bit
Ms. Corzo received 147,611 stock options under the 2020 Equity Incentive Plan, vesting over 36 months.
2 more takeaways
Related Filings (1)
1 more filing from Marker Therapeutics, Inc. in the last 90 days
Filing Overview
What This Means
Marker Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.